Literature DB >> 18164258

Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation.

Xiujuan Qu1, Yunpeng Liu, Yanju Ma, Ye Zhang, Yingchun Li, Kezou Hou.   

Abstract

The Casitas B-lineage Lymphoma (Cbl) family of ubiquitin ligases is multifunctional proteins that play important roles in different cell signaling pathways. It has been reported that c-Cbl and Cbl-b mRNAs are up-regulated during TPA-induced U937 and HL-60 cell differentiation. But the mechanism of the up-regulation and the roles of the Cbl family of ubiquitin ligases still remain unclear. In the present study, we demonstrated that bufalin enhanced all-trans retinoic acid (ATRA) induced differentiation of HL-60 cells, accompanied by up-regulation of the Cbl family of ubiquitin ligases. CsA, an inhibitor of calcium mobilization, reversed this up-regulation. Pretreatment with CsA and PS-341 did not affect the expression of CD11b, but suppressed the percentage of adherent cells. Lipid raft localization of Cbl-b enhanced cell adhesion, while C-terminal deletion partially suppressed the effect. Moreover, the expression of the adhesion-related kinases Pyk2 and Paxillin was up-regulated in parallel with the increase of Cbl proteins. These results suggested that up-regulation of c-Cbl and Cbl-b was involved in the regulation of ATRA and bufalin-induced HL-60 cell adhesion rather than cell differentiation, which might be mediated by lipid raft localization, ubiquitin ligase activity and C-terminal structure of Cbl proteins. Meanwhile, up-regulation of proline-rich tyrosine kinase (Pyk2) and Paxillin might also be implicated in this regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164258     DOI: 10.1016/j.bbrc.2007.12.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.

Authors:  Xiujuan Qu; Yingchun Li; Jing Liu; Ling Xu; Ye Zhang; Xuejun Hu; Kezuo Hou; Yunpeng Liu
Journal:  Mol Cell Biochem       Date:  2010-02-24       Impact factor: 3.396

2.  Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2.

Authors:  Yibo Fan; Xiujuan Qu; Yanju Ma; Jinglei Qu; Yunpeng Liu; Xuejun Hu
Journal:  Tumour Biol       Date:  2014-08-07

3.  Cbl-b promotes cell detachment via ubiquitination of focal adhesion kinase.

Authors:  Yibo Fan; Xiujuan Qu; Yanju Ma; Yunpeng Liu; Xuejun Hu
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

4.  c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.

Authors:  Miaoqing Shen; Andrew Yen
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

5.  Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.

Authors:  Lei Zhao; Shizhou Liu; Xiaofang Che; Kezuo Hou; Yanju Ma; Ce Li; Ti Wen; Yibo Fan; Xuejun Hu; Yunpeng Liu; Xiujuan Qu
Journal:  Int J Mol Med       Date:  2015-06-30       Impact factor: 4.101

Review 6.  Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.

Authors:  Armando Cevenini; Stefania Orrù; Annamaria Mancini; Andreina Alfieri; Pasqualina Buono; Esther Imperlini
Journal:  Int J Mol Sci       Date:  2018-08-15       Impact factor: 5.923

7.  Rs4911154 of circ-ITCH aggravated tumor malignancy of thyroid nodules via the circ-ITCH/miR-22-3p/CBL axis.

Authors:  Yiqing Guo; Hua Zheng; Jie Yin; Huaming Wang
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

8.  Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.

Authors:  Heming Li; Ling Xu; Ce Li; Lei Zhao; Yanju Ma; Huachuan Zheng; Zhi Li; Ye Zhang; Ruoyu Wang; Yunpeng Liu; Xiujuan Qu
Journal:  Mol Cancer       Date:  2014-06-02       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.